All In Biotech

Drug Trial Radar · NCT00963209

Tamoxifen Citrate in Patients With Breast Cancer

Tamoxifen Metabolism and the Impact of Tamoxifen Dose on the Level of the Active Metabolites in Endocrine Sensitive Breast Cancer Patients

Last checked: Nov 19, 2026Latest source record: Aug 2, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

140

Planned (sponsor's estimate)

Start

Jun 2009

Primary completion

Sep 2013

Study completion Dec 2013

Sponsor

Lead sponsor
Centre Hospitalier Universitaire VaudoisAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 21, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Estrogen can promote growth of endocrine sensitive breast cancer cells. Endocrine therapy with tamoxifen citrate may fight breast cancer by blocking the use of estrogen by the tumor cells. Pharmacokinetics and -genomics can have an impact on the efficacy of the treatment. PURPOSE: This phase III trial is studying blood samples to see if the level of active metabolites of tamoxifen can be improved in patients with breast cancer.

Conditions

  • Breast Cancer

Interventions

  • tamoxifen citrateDrug

  • laboratory biomarker analysisOther

  • pharmacological studyOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determination of CYP2D6 genotype and determination of plasma concentrations of tamoxifen citrate and its metabolites (N-desmethyl-tamoxifen, 4-hydroxy-tamoxifen and endoxifen) under the 20 mg daily and 40 mg daily schedulesTime frame: Jan 2013

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Hôpitaux Universitaire de Genève

    Geneva, Switzerland · Recruiting

  • Centre Hospitalier Universitaire Vaudois

    Lausanne, Switzerland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.